Current Technology Corp. (CRTCF)
Interview with:
Robert Kramer, CFO
Business News, Financial News, Stocks, Money & Investment Ideas, CEO Interview
and Information on their
patented electrotherapeutic device which reduces excessive hair loss and can stimulate hair regrowth.

wpe4D.jpg (6486 bytes)

Cover Story

CEOCFO Interview Index

CEOCFO Current Issue

Future Features

Analyst Interviews

Corporate Financials

Archived Interviews
 

About CEOCFOinterviews.com

Contact & Ordering

 

Current Technology Corp. – finding their technology for reducing hair loss applicable to women taking chemotherapy for breast cancer as well as men

wpe5B.jpg (2137 bytes)

Healthcare
Spa Industries
(CRTCF:OTC)

Current Technology Corp.

 wpe61.jpg (7358 bytes)

Robert Kramer
Chief Financial Officer

Diane Reynolds
Co Publisher

CEOCFOinterviews.com
September 2003

Current Technology Corporation has developed a patented electrotherapeutic device which reduces excessive hair loss and can stimulate hair regrowth in those who suffer from androgenetic alopecia (common baldness).   ElectroTrichoGenesis, or ETG Treatment, the regrowth of hair by means of electrical stimulation, promotes the “healing” of hair follicles that are dormant, but not dead.  Research has recently been conducted to expand the indications for ETG.   For example, a single center pilot trial to assess the efficacy of ETG in the reduction of hair loss in patients with breast cancer undergoing CMF chemotherapy has been completed with encouraging results.  Psycho-Oncology, a peer reviewed medical journal, published the results in the May/June 2002 edition (p.244-248). “We are at the front end of what we see as a successful launch of our cosmetic CTG Mark 5 product into the largest market for cosmetic products in the world.” Says Mr. Robert Kramer, CFO of Current Technology Corp.; “In the world today you have two things that are converging that I think are very exciting for Current Technology. The first is you have a population generally but most typically in the United States that is very sophisticated and aware of concepts of wellness and physical appearance and as people get older, they want to maintain their youthful look and feel as long as possible and we are a part of that. Secondly, looking at it from an operator standpoint, we live in a world today where individuals who are in business are searching for different areas of revenue that may be available to them for modest investments and we feel we really fit the bill.” Pointing to significant changes in the market place Mr. Kramer told us,  “When my wife and I co-founded the company, we saw this technology platform as one to be directed at males and I think that was probably a reasonable assumption on a first look basis.   However, as we have gotten further into it we feel it is going to be significant for women and are very excited about its prospects.  Definitely on the cosmetic side, this relates to how concerned women are of any issues relating to the appearance of their hair.”

“Historically we have focused on countries outside of the US and we are certainly anxious to continue that process, but we have very recently developed a product for the U.S. market and that product is called CosmeticTrichoGenesis (CTG) or the CTG Mark 5 unit.” Offers Mr. Kramer, commenting on new product developments and the marketplace. “Recognizing that we would not have the ability to build a global infrastructure as we are a small company, we have devoted our talents on the front end to developing a communication system that allows us at our head office to communicate with the device all around the world via a modem.  Once it is hooked up, there are signals that are sent from the control processing unit which is the brain of the unit to our computers here in our head offices. We are then able to read all of the historical treatments that have been given to determine that they have been given in the appropriate manner. It will carry out a full systems check and if there is something wrong it identifies exactly what the problem is and allows us to direct a fix on a remote basis. It is quite an interesting system. It is security controlled and it is working extremely well for us. Also I think your readers will be interested to note that this allows us to in most instances  participate in downstream revenue.  Therefore we not only generate revenue from the sale of an ETG device at the front end but in most cases participate on a per treatment basis downstream. We are able to monitor that by monitoring the equipment through the process that I just described.”

Over the years, researchers and clinicians have discovered that certain electrical frequencies and current values stimulate healing responses in various parts of the body.  For example, a research paper published in The Journal of Bone and Joint Surgery in May 1990 by J. W. Sharrard, M.D., University of Sheffield, concluded that electrical stimulation significantly influenced healing in non-union fractures.  In addition, a report published in the British Journal of Dermatology in 1992 presented evidence on the healing of recalcitrant venous ulcers by means of electrical stimulation.  Electrical stimulation is now an accepted medical treatment in a number of specific areas.

The company has focused on developing a treatment for common baldness using electrical stimulation.  It has identified the electrical parameters that reduce excessive hair loss and stimulate hair regrowth, and it has developed the treatment program.  As hair loss progresses, the hair follicle produces hairs in the normal growing-resting-shedding cycle that are progressively thinner and shorter.   Ultimately only “peach fuzz” type hair is produced and then the hair follicle goes into a dormant state prior to its demise.  ETG Treatment alters this dormant state by stimulating the production capability of the follicle and thereby reducing excessive hair loss and encouraging regrowth.



Instant Access:

To find out more about:
Current Technology Corp. (CRTCF) you may order the complete text of our interview. To view a copy of this highly informative interview, left click here: ViewCRTCF

disclaimer

Newsflash!

To view Releases highlight & left click on the company name!

 

ceocfointerviews.com does not purchase or make
recommendation on stocks based on the interviews published.

.